v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]      
Net sales $ 1,193,451 $ 963,027 $ 1,013,540
Cost of products sold 834,020 637,347 638,702
Gross profit 359,431 325,680 374,838
Selling expenses 133,579 110,043 105,341
General and administrative expenses 178,325 107,249 106,760
Research and development expenses 21,409 23,869 26,193
Net gain on sales of businesses (103,306) 0 0
Loss on impairment of goodwill 200,000 0 0
Amortization of intangibles 48,757 29,946 29,396
Income from operations (119,333) 54,573 107,148
Interest and debt expense 61,145 32,426 37,957
Cost of debt refinancing 24,185 0 0
Investment (income) loss, net (2,182) (1,302) (1,759)
Foreign currency exchange loss (gain), net 5,551 3,179 1,826
Other (income) expense, net (1,525) 25,775 7,597
Income (Loss) before income tax expense (206,507) (5,505) 61,527
Income tax (benefit) expense 22,930 (367) 14,902
Net income (loss) (229,437) (5,138) 46,625
Net loss attributable to noncontrolling interest 98 0 0
Net income (loss) attributable to the Company $ (229,535) $ (5,138) $ 46,625
Average basic shares outstanding (in shares) 28,714 28,738 28,728
Average diluted shares outstanding (in shares) 28,714 28,738 29,026
Basic income (loss) per common share (in dollars per share) $ (7.40) $ (0.18) $ 1.62
Diluted income (loss) per common share (in dollars per share) (7.40) (0.18) 1.61
Dividends declared per common share (in dollars per share) $ 0.28 $ 0.28 $ 0.28